The funding was meant to help the U.S. prepare for pandemics triggered by avian flu strains, but now leaves the future of ...

After a three-year drought, the industry is questioning whether the window for medtech public offerings is open following a ...

A therapy at the center of their $22 billion alliance failed to extend survival in a type of lung tumor, leading the ...